Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Biomerica, Inc. BMRA
$1.23
+$0.01 (0.82%)
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
20692250.00000000
-
week52high
5.25
-
week52low
1.18
-
Revenue
18871409
-
P/E TTM
-3
-
Beta
-0.61660800
-
EPS
-0.54000000
-
Last Dividend
0.00000000
-
Next Earnings Date
14 апр 2023 г. в 20:48
Описание компании
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome therapy technology and diagnostic-guided therapy; Helicobacter pylori products, as well as develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Aegis Capital | Buy | Buy | 19 окт 2020 г. |
| Aegis Capital | Buy | Buy | 04 сент 2020 г. |
| Aegis Capital | Buy | 21 авг 2020 г. | |
| B. Riley FBR | Buy | Buy | 17 дек 2018 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| BARBIERI ALLEN | A | 101327 | 1538 | 27 янв 2023 г. |
| Coste Catherine | A | 43790 | 2190 | 26 янв 2023 г. |
| Irani Zackary S. | A | 1005960 | 1800 | 25 янв 2023 г. |
| Irani Zackary S. | A | 1004160 | 2000 | 24 янв 2023 г. |
| BARBIERI ALLEN | D | 107289 | 7500 | 20 дек 2021 г. |
| Irani Zackary S. | A | 733616 | 100000 | 09 дек 2021 г. |
| Sloan Steven | A | 115000 | 40000 | 09 дек 2021 г. |
| Sirgo Mark A | A | 170000 | 25000 | 09 дек 2021 г. |
| BARBIERI ALLEN | A | 265000 | 45000 | 09 дек 2021 г. |
| Emerson Jane | A | 190000 | 25000 | 09 дек 2021 г. |
Новостная лента
Biomerica stock leaps as Walmart expands sales of Aware Breast Self Exam to its stores
Market Watch
14 окт 2022 г. в 09:46
Shares of Biomerica Inc. BMRA, +7.58% shot up 13.1% toward a 6-month high in active morning trading Friday, after the medical diagnostic products company said Walmart Inc. WMT, +0.45% will start selling its Aware Breast Self Exam device in about half its stores. Trading volume ballooned to 1.8 million shares, compared with the full-day average of about 57,200 shares.
Walmart to Start Selling Biomerica's Aware Breast Self Exam Devices
Benzinga
14 июл 2022 г. в 11:59
Biomerica Inc (NASDAQ: BMRA) announced that its Aware Breast Self Exam device will now be sold in Walmart Inc's (NYSE: WMT) retail system. The Biomerica FDA-cleared Aware Breast Self Exam device is a way for women to enhance tactile sensitivity to changes or.